DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 1.33% to $6.88 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.18% to 17,436.10 and Dow Jones Industrial Average falling 1.14% to 41,433.48.
Corbus Pharmaceuticals Holdings Inc. closed 88.89% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 5.73% to $4.98, Fortress Biotech Inc. (FBIO) fell 0.57% to $1.73, and Viking Therapeutics Inc. $(VKTX)$ fell 5.15% to $26.52.
Trading volume (241,369) remained 7,175 below its 50-day average volume of 248,544.
Data source: Dow Jones Market Data, FactSet. Data compiled March 11, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 11, 2025 17:24 ET (21:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.